Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on NAD Independent Dehydrogenase. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101333554B reveals enzymatic resolution for D-lactic acid. Achieve high optical purity and cost reduction in pharmaceutical intermediates manufacturing with scalable biocatalysis.
Patent CN101974603B reveals a novel NAD-independent enzymatic resolution method for high-purity D-alpha-hydroxybutyric acid, offering significant cost reduction and scalable supply chain solutions.